Home | Staff Directory

Recent content from Janet Moore

• Study by Medtronic consultant comes under fire
  A highly regarded surgeon and Medtronic consultant is under investigation for an allegedly fraudulent medical study involving an orthopedic product made by the med-tech giant.
  Jul 12, 2009
• Medtronic recalls insulin infusion equipment
  The potential malfunction could lead to serious injury, even death.
  Jul 11, 2009
• Synovis Life buys assets of tissue repair products firm
  A St. Paul firm wins a bidding contest for a California company that sells biologic materials used in orthopedic surgery.
  Jul 8, 2009
• Payment disclosures: 'Compliance in name only'
  A Minnesota law requiring drugmakers to report payments to medical practitioners is generating data that is incomplete, inconsistent and hard to search.
  Jul 6, 2009
• Medtronic's Infuse widely used despite cost, risks
  A prominent medical journal said more than 25 percent of spinal fusion surgeries use bone-growth products, which can cause complications in "off-label" uses.
  Jul 1, 2009
• State's med-tech boom slows to a crawl
  Investors are shying away from medical device firms as cost pressures mount.
  Jun 21, 2009
• Park Nicollet CEO to retire
  After 11 years at the helm, David Wessner will stay on until the end of the year at the Twin Cities' smallest hospital and clinic group.
  Jun 20, 2009
• CyberOptics founder killed in Crystal crash
  CyberOptics founder Steven Case was killed Tuesday when the plane he was flying crashed in Crystal. He is remembered as a brilliant scientist and principled entrepreneur.
  Jun 18, 2009
• Mayo, doc leave clinic for courtroom
  Dr. Peter Elkin and his former employer are in a virulent battle over who owns software that could revolutionize record-keeping.
  Jun 14, 2009
• Med-tech firms spent heavily on military travel
  Companies say they need input of medical personnel on their products and need to train them on use, but critics cry conflict of interest. The companies say they need doctors' input; but critics cry it's a conflict of interest.
  Jun 11, 2009

Next page